![]() |
인쇄하기
취소
|
Some domestic pharmaceutical companies has acquired the exclusive sales right of Januvia generics, the antidiabetic treatment which can be launched in 8 years after the year of 2023.
This is because the Januvia’s salt and crystalline patents are now nullified. So far, the domestic companies have continued a fierce cold war to earn the exclusive sales right for the 8 year later.
The patent law...